Author’s reply to the Letter to the Editor “Therapeutic strategies in the treatment of Menière's disease: the Italian experience”

被引:0
|
作者
N. Quaranta
P. Picciotti
机构
[1] University of Bari,Otolaryngology Unit, Department of BMS, Neuroscience and Sensory Organs
[2] Catholic University of Sacred Heart,Department of Head and Neck Surgery, Otorhinolaryngology
[3] UOC Otorinolaringoiatria Universitaria,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
There is still controversy on the role of hyperinsulinemia and endogenous antisecretory factor (EAF) in Meniere’s disease. In the literature, there is no mention on glucose uptake or specially processed cereals (SPC). Nevertheless, the role of EAF and its inhibition by SPC should be taken into account in future research. In case of patients not responding to medical treatment and dietary changes, intratympanic (IT) treatment has been suggested. In Italy, generalists consider IT steroids as the first-line treatment, while neurotologists suggest IT gentamicin. We agree with the authors that low-dose IT gentamicin has a high chance to treat vertigo with minimal risks for hearing; however, a recent randomized, double-blind, comparative trial has not proven the superiority of gentamicin to IT steroids suggesting the choice “should be made based on clinical knowledge and patient circumstances”. IT steroids have the advantage to preserve both cochlear and vestibular function, while IT gentamicin has an ablative effect especially on the vestibular function.
引用
收藏
页码:1849 / 1850
页数:1
相关论文
共 50 条
  • [31] Author's reply on letter to editor "Apocrine carcinoma is the fact" by Vranic S
    Gurrado, Angela
    Serio, Gabriella
    Marzullo, Andrea
    BREAST JOURNAL, 2020, 26 (04): : 839 - 840
  • [32] Letter to the editor re initial experience with per-rectal endoscopic myotomy for Hirschsprung's disease Reply
    Dashatwar, Parag
    Biradar, Vishnu
    Bapaye, Amol
    ENDOSCOPY, 2022, 54 (05) : 526 - 526
  • [33] Menière’s disease with migraine, Menière’s disease without migraine and Vestibular migraine: clinical differences
    Gülden Akdal
    Tural Tanrıverdizade
    Koray Koçoğlu
    Pınar Özçelik
    Gabor Michael Halmagyi
    Alpin Güneri
    Günay Kırkım
    Journal of Neurology, 2023, 270 : 5635 - 5638
  • [34] Treating Menière's disease with rimegepant
    Hegemann, Stefan C. A.
    Schell, Angela
    SWISS MEDICAL WEEKLY, 2025, 155
  • [35] Intratympanic Therapies for Menière’s Disease
    Miller M.W.
    Agrawal Y.
    Current Otorhinolaryngology Reports, 2014, 2 (3) : 137 - 143
  • [36] Author's reply - To the editor
    Rosenquist, TH
    TERATOLOGY, 1999, 60 (02) : 58 - 60
  • [37] To the Editor - Author's reply
    Mathias, RG
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2000, 91 (04): : 273 - 273
  • [38] To the editor - The author's reply
    Marion, DW
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 58 (04): : 882 - 882
  • [39] Author's response to 'Evidence is in the eye of the beholder' letter to the editor Reply
    Ernst, Edzard
    Posadzki, Paul
    SUPPORTIVE CARE IN CANCER, 2013, 21 (12) : 3257 - 3257
  • [40] Letter to the editor - Editor's reply
    Poehling, GG
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2002, 18 (05): : 565 - 565